Mapping genetic interactions (GIs) by simultaneously perturbing pairs of genes is a powerful tool for understanding complex biological phenomena. Here we describe an experimental platform for generating quantitative GI maps in mammalian cells using a combinatorial RNA interference strategy. We performed ~11,000 pairwise knockdowns in mouse fibroblasts, focusing on 130 factors involved in chromatin regulation to create a GI map. Comparison of the GI and protein-protein interaction (PPI) data revealed that pairs of genes exhibiting positive GIs and/or similar genetic profiles were predictive of the corresponding proteins being physically associated. The mammalian GI map identified pathways and complexes but also resolved functionally distinct submodules within larger protein complexes. By integrating GI and PPI data, we created a functional map of chromatin complexes in mouse fibroblasts, revealing that the PAF complex is a central player in the mammalian chromatin landscape.
At a glance
- Quantitative genetic interactions reveal biological modularity. Cell 141, 739–745 (2010). , &
- Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature 446, 806–810 (2007). et al.
- A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing. Mol. Cell 32, 735–746 (2008). et al.
- Modelling genotype-phenotype relationships and human disease with genetic interaction networks. J. Exp. Biol. 210, 1559–1566 (2007).
- The genetic landscape of a cell. Science 327, 425–431 (2010). et al.
- Hierarchical modularity and the evolution of genetic interactomes across species. Mol. Cell 46, 691–704 (2012). et al.
- High-throughput, quantitative analyses of genetic interactions in E. coli. Nat. Methods 5, 781–787 (2008). et al.
- Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 38, 896–903 (2006). , , , &
- Mapping of signaling networks through synthetic genetic interaction analysis by RNAi. Nat. Methods 8, 341–346 (2011). et al.
- Global mapping of the yeast genetic interaction network. Science 303, 808–813 (2004). et al.
- Quantitative analysis of fitness and genetic interactions in yeast on a genome scale. Nat. Methods 7, 1017–1024 (2010). et al.
- Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell 123, 507–519 (2005). et al.
- Genomic screening with RNAi: results and challenges. Annu. Rev. Biochem. 79, 37–64 (2010). , &
- High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing. Genome Biol. 12, R104 (2011). et al.
- Enzymatically prepared RNAi libraries. Nat. Methods 3, 696–700 (2006). , , &
- Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies. Nat. Methods 4, 337–344 (2007). et al.
- Quantitative genetic interaction mapping using the E-MAP approach. Methods Enzymol. 470, 205–231 (2010). , &
- A cell spot microarray method for production of high density siRNA transfection microarrays. BMC Genomics 12, 162 (2011). et al.
- A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67–73 (1999). , &
- A strategy for extracting and analyzing large-scale quantitative epistatic interaction data. Genome Biol. 7, R63 (2006). , , &
- A comprehensive strategy enabling high-resolution functional analysis of the yeast genome. Nat. Methods 5, 711–718 (2008). et al.
- Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 21, 1109–1121 (2011). , , , &
- Functional maps of protein complexes from quantitative genetic interaction data. PLOS Comput. Biol. 4, e1000065 (2008). , , &
- Rewiring of genetic networks in response to DNA damage. Science 330, 1385–1389 (2010). et al.
- Conserved rules govern genetic interaction degree across species. Genome Biol. 13, R57 (2012). et al.
- A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4, 403–415 (2009). et al.
- RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach. Mol. Cell. Biol. 22, 6979–6992 (2002). et al.
- Facts about FACT and transcript elongation through chromatin. Curr. Opin. Genet. Dev. 14, 139–146 (2004). &
- The Ccr4–not complex. Gene 492, 42–53 (2012). &
- Human Ccr4-Not complexes contain variable deadenylase subunits. Biochem. J. 422, 443–453 (2009). et al.
- The INO80 chromatin remodeling complex in transcription, replication and repair. Trends Biochem. Sci. 34, 71–77 (2009). &
- snRNA 3′ end formation: the dawn of the Integrator complex. Biochem. Soc. Trans. 38, 1082–1087 (2010). &
- Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 6, 476–486 (2005). &
- Cohesin: its roles and mechanisms. Annu. Rev. Genet. 43, 525–558 (2009). &
- Deciphering condensin action during chromosome segregation. Trends Cell Biol. 21, 552–559 (2011). &
- Control of transcription by Pontin and Reptin. Trends Cell Biol. 17, 187–192 (2007).
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Res. 72, 5588–5599 (2012). et al.
- Multiple genetic interaction experiments provide complementary information useful for gene function prediction. PLOS Comput. Biol. 8, e1002559 (2012). &
- The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim. Biophys. Acta 1799, 379–388 (2010).
- Image-based multivariate profiling of drug responses from single cells. Nat. Methods 4, 445–453 (2007). , &
- Nucleolar localization of the Werner syndrome protein in human cells. Proc. Natl. Acad. Sci. USA 95, 6887–6892 (1998). , , &
- Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome. J. Biol. Chem. 282, 12851–12859 (2007). et al.
- Supplementary Text and Figures (13.5 MB)
Supplementary Figures 1–9, Supplementary Tables 1,4,5
- Supplementary Table 2 (37 KB)
Significant GIs observed (−2 ≤ S ≥ 2).
- Supplementary Table 3 (74 KB)
Oligonucleotides used to generate esiRNAs.